| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 38.5% | 10/26 |
| Female | 61.5% | 16/26 |
| Indifferent | 0% | 0/26 |
| Unknown | 0% | 0/26 |
| General | ||
| 3.8% | 1/26 | |
| 7.7% | 2/26 | |
| 3.8% | 1/26 | |
| 76.9% | 20/26 | |
| 46.2% | 12/26 | |
| 69.2% | 18/26 | |
| 88.5% | 23/26 | |
| 92.3% | 24/26 | |
| 76.9% | 20/26 | |
| 86.4% | 19/22 | |
| Neurology | ||
| 96.2% | 25/26 | |
| 7.7% | 2/26 | |
| 50% | 13/26 | |
| Facial abnormalities | ||
| Abnormality of the ear | 3.8% | 1/26 |
| 73.1% | 19/26 | |
| Abnormality of the nose | 57.7% | 15/26 |
| 15.4% | 4/26 | |
| Visual and hearing impairments | ||
| 46.2% | 12/26 | |
| 50% | 13/26 | |
| Heart | ||
| 7.7% | 2/26 | |
| Pulmonary | ||
| 4.2% | 1/24 | |
| Gastrointestinal | ||
| 19.2% | 5/26 | |
| Urogenital | ||
| 3.8% | 1/26 | |
| Skeleton | ||
| 30.8% | 8/26 | |
| Skin / Hair / Nails | ||
| 15.4% | 4/26 | |
| Endocrine / Immunological / Metabolic | ||
| 42.3% | 11/26 | |
| 3.8% | 1/26 | |
| 3.8% | 1/26 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/26 |
| Inheritance | ||
| 80% | 20/25 | |
MORC2